3rd Quarter - Report

THE NICKLES GROUP, LLC for JOHNSON & JOHNSON SERVICES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Monitored the American Jobs Plan, as it relates to corporate and international taxes

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues related to maternal health.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Issues related to Medicare coverage of vaccines. Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to COVID relief. Issues related to maternal health. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to drug pricing.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3 (117th), H.R. 3684 (117th), S. 2164 (117th), H.R. 19 (117th), H.R. 5376 (117th)

Budget/Appropriations BUD

Monitored S.Con.Res.14, FY 2022 Budget Resolution, as it relates to drug pricing and S.2428, The False Claims Amendments Act of 2021.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (117th), S. 2428 (117th)

Consumer Issues/Safety/Products CSP

S. 1425, Stop STALLING Act, S. 1428, Preserve Access to Affordable Generics and Biosimilars Act, S. 1388, Prescription Pricing for the People Act of 2021, and S. 1435, Affordable Prescriptions for Patients Act of 2021.

LobbyistCovered position, as disclosed
JEFF CHOUDHRY New U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1388 (117th), S. 1435 (117th), S. 1425 (117th), S. 1428 (117th)

Government Issues GOV

Issues related to Medicare coverage of vaccines. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19, the Lower Costs, More Cures Act. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to drug pricing.

LobbyistCovered position, as disclosed
BRETT BAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3684 (117th), H.R. 5376 (117th), H.R. 19 (117th), H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.